TransMedics Group's GAAP loss for the 3 months of 2022 was $10.562 million, up 33.4% from $7.917 million in the previous year. Revenue increased 2.3 times to $15.88 million from $7.053 million a year earlier.
TransMedics Group's GAAP loss for the 3 months of 2022 was $10.562 million, up 33.4% from $7.917 million in the previous year. Revenue increased 2.3 times to $15.88 million from $7.053 million a year earlier. 
English (US) 